Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FSYD7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,131
Award facts
- Contract value 100% obligated
- $24,131.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,131.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg in pre-filled pen format on January 16, 2026, with completion scheduled for January 20, 2026. This award is a non-set-aside competitive contract executed through AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The product will be performed and delivered from the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order reflects AmerisourceBergen's critical role in supplying specialty pharmaceutical products to support military healthcare systems globally. Cosentyx is a biologic immunosuppressant used to treat autoimmune inflammatory conditions, demonstrating the vendor's capability to deliver high-value specialty medications alongside its comprehensive portfolio of brand-name drugs, generics, vaccines, and medical supplies. The contract execution under the larger IDC vehicle enables efficient procurement of essential pharmaceutical commodities required by military treatment facilities and other federal healthcare institutions within the Defense Health Agency's operations.
Quick answers
Who was awarded contract SPE2DR26FSYD7?
SPE2DR26FSYD7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FSYD7 worth?
The government has obligated $24,131 on SPE2DR26FSYD7.
Is contract SPE2DR26FSYD7 an order under another contract?
Yes. SPE2DR26FSYD7 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSYD7 competed?
The extent of competition for SPE2DR26FSYD7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award